Seres Therapeutics (MCRB) Reports Q3 EPS of $0.72

Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of $0.72. Revenue for the quarter came in at $126.7M.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• DA Davidson flags Duolingo DAU momentum stalling, keeps Neutral at $120
• Hertz Global (HTZ) PT Lowered to $3.50 at Morgan Stanley